Table 1.
Correlation between eGREB1 expression and clinicopathological characteristics of BCa patients
| Characteristics | Total | eGREB1 expression | P value | |
|---|---|---|---|---|
| Low | High | |||
| Gender | ||||
| Female | 7 | 1 (14.3%) | 6 (85.7%) | 0.517 |
| Male | 31 | 8 (25.8%) | 23 (74.2%) | |
| Age | ||||
| ≤60 | 10 | 4 (40.0%) | 6 (60.0%) | 0.252 |
| >60 | 28 | 6 (21.4%) | 22 (78.6%) | |
| Histological grade | ||||
| Low | 15 | 10 (66.7%) | 5 (33.3%) | 0.001** |
| High | 23 | 3 (13.0%) | 20 (87.0%) | |
| Depth of invasion (T) | ||||
| Ta, T1 | 9 | 7 (77.8%) | 2 (22.2%) | 0.004** |
| T2, T3, T4 | 29 | 7 (24.1%) | 22 (75.9%) | |
| Lymph node metastasis (N) | ||||
| N0 | 36 | 7 (19.4%) | 29 (80.6%) | 0.490 |
| N1, N2, N3 | 2 | 0 (0.0%) | 2 (100.0%) | |
| TNM stage | ||||
| 0/I | 6 | 4 (66.7%) | 2 (33.3%) | 0.003** |
| II/III/IV | 32 | 4 (12.5%) | 28 (87.5%) | |
*P < 0.05 was considered significant; **P < 0.01.